Orthofix International (OFIX) Tops Q4 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
February 25, 2022 7:00 AM ESTFourth quarter net sales of $125.1 million, an increase of 6% over the prior year 2021 annual net sales of $464.5 million, an increase of 14% over the prior year Double-digit net sales growth in the quarter and for the year compared to the prior year period for both global Spinal Implants and Orthopedics Entered into a partnership and investment with nView medical, developer of novel imaging and guidance systems
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today... More



